Showing: 1 - 3 of 3 RESULTS
Amanita Muscaria Briefing Compass Pathways Professor David Nutt Psyched Wellness Psychedelics The Daily Dive Video Series

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the chair of the scientific advisory board for Compass Pathways (NASDAQ: CMPS), and a director of Psyched Wellness (CSE: PSYC). David joins us this morning to discuss psychedelics and the science behind it, clinical research, and …

Amanita Muscaria Briefing News Psyched Wellness Psychedelics

Psyched Wellness Sees Positive Results From Amanita Muscaria Toxicology Report

Psyched Wellness (CSE: PSYC) has completed its toxicology assessment on that of Amanita Muscaria, the firms core focus when it comes to psychedelic and functional mushrooms. The assessment, which was conducted by contract research organization KGK Sciences, has reported positive results for the company with the key finding being that the mushroom should be classified …

Amanita Muscaria Briefing News Psyched Wellness Psychedelics

Psyched Wellness Adds Amanita Muscaria Expert To Advisory Board

Kevin Feeney has joined the advisory board of that of Psyched Wellness (CSE: PSYC) as of this morning. Feeney will be working with the company to identify novel uses for the psychoactive constituent in Amanita Muscaria, which is known as Muscimol. Feeny is a cultural anthropologist and lawyer, whom current serves as program director as …